August 1, 1999· The Lancet
article
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
Authors:BJ RembackenAM SnellingPM HawkeyDM ChalmersATR Axon
Abstract
No abstract metadata is available for this record.
Community
0 commentsUse Connect Wallet in the navigation
No discussion yet
Be the first to share a question or observation.